The Patent Finder

Rexahn Corporation

Also on record
Records under this name other than patents Rexahn Corporation holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 3 of 3 · Back to Rexahn Corporation

PatentTitleStatus Expires Confidence
US 7,405,214Nucleoside derivatives and therapeutic use thereof
Formerly held
Term ended
Term ended Aug 24, 2025 · From the USPTO record
Term endedTerm ended Aug 24, 2025From the USPTO record
US 7,205,283Antisense oligonucleotides that inhibit expression of HIF-1
Formerly held
Term ended
Term ended Jun 16, 2025 · From the USPTO record
Term endedTerm ended Jun 16, 2025From the USPTO record
US 7,122,527Use of antisense oligonucleotides to inhibit the expression of human Akt-1
Formerly held
Term ended
Term ended Feb 10, 2025 · From the USPTO record
Term endedTerm ended Feb 10, 2025From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited